Cited by 335Pharmaceutical industry and healthcareEthics in Clinical ResearchHealthcare Regulation

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Trial Reporting in ClinicalTrials.gov — The Final Rule

Open access

Zarin, Deborah A., Tse, Tony, Williams, Rebecca J., Carr, Sarah·2016·New England Journal of Medicine

Open this paper in CoChat — free account Open PDF

Abstract

B) an amount equal to the modified workload adjustment factor for fiscal year 2007 (as determined under paragraph (3)). ''(2) TYPES OF FEES.-Of the total revenue amount determined for a fiscal year under paragraph (1)-''(A) one-third shall be derived from fees under subsection (a)(1) (relating to human drug applications and supplements); ''(B) one-third shall be derived from fees under subsection (a)(2) (relating to prescription drug establishments); and ''(C) one-third shall be derived from fees under subsection (a)(3) (relating to prescription drug products). ''(3) MODIFIED WORKLOAD ADJUSTMENT FACTOR FOR FISCAL YEAR 2007.-For purposes of paragraph (1)(B), the Secretary shall determine the modified workload adjustment factor by determining the dollar amount that results from applying the methodology that was in effect under subsection (c)(2) for fiscal year 2007 to the amount $354,893,000, except that, with respect to the portion of such determination that is based on the change in the total number of commercial investigational new drug applications, the Secretary shall count the number of such applications that were active during the most recent 12month period for which data on such submissions is available.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmsr1611785

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors
De Angelis, C., Drazen, J. M., Frizelle, F. A., Haug, C., Hoey, J., Horton, R., Kotzin, S., Laine, C., Marusic, A., Overbeke, A. J. P. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejme048225 · Cited by 1,241
Increasing value and reducing waste: addressing inaccessible research
Chan, A.-W., Song, F., Vickers, A., Jefferson, T., Dickersin, K., Gøtzsche, P. C., Krumholz, H. M., Ghersi, D., & van der Worp, H. B. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62296-5 · Cited by 887
The ClinicalTrials.gov Results Database — Update and Key Issues
Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1012065 · Cited by 838
Self-citation
Compliance with Results Reporting at ClinicalTrials.gov
Anderson, M. L., Chiswell, K., Peterson, E. D., Tasneem, A., Topping, J., & Califf, R. M. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1409364 · Cited by 380
Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals
Riveros, C., Dechartres, A., Perrodeau, E., Haneef, R., Boutron, I., & Ravaud, P. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001566 · Cited by 269
Issues in the Registration of Clinical Trials
Zarin, D. A., Ide, N. C., Tse, T., Harlan, W. R., West, J. C., & Lindberg, D. A. B. (2007) · JAMA · doi:10.1001/jama.297.19.2112 · Cited by 228
Self-citation
Toward a New Era of Trust and Transparency in Clinical Trials.
Hudson, K., Lauer, M., & Collins, F. (2016) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2016.14668 · Cited by 132
The Evolution of Trial Registries and Their Use to Assess the Clinical Trial Enterprise
Dickersin, K. (2012) · JAMA · doi:10.1001/jama.2012.4230 · Cited by 127
The Proposed Rule for U.S. Clinical Trial Registration and Results Submission
Zarin, D. A., Tse, T., & Sheehan, J. (2014) · New England Journal of Medicine · doi:10.1056/nejmsr1414226 · Cited by 103
Self-citation
Clinical Trials Registration and Results Information Submission. Final rule.
(2016) · PubMed · Cited by 101

Show all 11 references

Research works printed but not linked: 3

Department of Health and Human Services, 2016, Fed Regist, 81, 64981
National Institutes of Health, 2016, Fed Regist, 81, 64922
Hudson KL, JAMA

Sorted by citations

Items 101–200 of 335

COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective
Nishiwaki, S., & Ando, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.812370 · Cited by 19
Clearinghouse Standards of Evidence on the Transparency, Openness, and Reproducibility of Intervention Evaluations
Mayo‐Wilson, E., Grant, S., & Supplee, L. H. (2021) · Prevention Science · doi:10.1007/s11121-021-01284-x · Cited by 25
Assessment of Reported Trial Characteristics, Rate of Publication, and Inclusion of Mandatory Biopsies of Research Biopsies in Clinical Trials in Oncology
Parseghian, C. M., Tam, A. L., Yao, J. C., Ensor, J., Ellis, L. M., Raghav, K. P. S., & Overman, M. J. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4640 · Cited by 19
Dynamic clinical trial success rates for drugs in the 21st century
Zhou, Y., Zhang, Y., Xu, H., Chen, Z., Huang, S., Li, Y., Fu, J., Zhang, H., Zhao, D., Lian, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64552-2 · Cited by 20
Neurology trial registrations on ClinicalTrials.gov between 2007 and 2018: A cross-sectional analysis of characteristics, early discontinuation, and results reporting
Turner, B. E., Magnani, C. J., Frolov, A., Weeks, B. T., Steinberg, J. R., Huda, N., Shah, L. M., Zuroff, L. R., Gu, B. J., Rasmussen, H. K., et al. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117579 · Cited by 18
Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review
Teo, M. T. W., McParland, L., Appelt, A. L., & Sebag‐Montefiore, D. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.09.042 · Cited by 19
The Path to Perfect Pediatric Posology — Drug Development in Pediatrics
Korth-Bradley, J. M. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1081 · Cited by 18
Data Sharing and Cardiology
Dey, P., Ross, J. S., Ritchie, J. D., Desai, N. R., Bhavnani, S. P., & Krumholz, H. M. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.037 · Cited by 18
Enhancing patient-level clinical data access to promote evidence-based practice and incentivize therapeutic innovation
Fortunato, A., Grainger, D. W., & Abou‐El‐Enein, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.017 · Cited by 17
Not Reporting Results of a Clinical Trial Is Academic Misconduct
Wallach, J. D., & Krumholz, H. M. (2019) · Annals of Internal Medicine · doi:10.7326/m19-1273 · Cited by 18
Racial, Ethnic, and Gender Diversity in United States Ophthalmology Clinical Trials
Montazeri, F., Wang, M. C., Atkuru, A., Estrada, M. M., Liu, Y., & Emami-Naeini, P. (2023) · Ophthalmology Science · doi:10.1016/j.xops.2023.100402 · Cited by 16
Clinical trial registry use in anaesthesiology systematic reviews
Umberham, B. A., Detweiler, B., Sims, M. T., & Vassar, M. B. (2017) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000671 · Cited by 16
Is it time for computable evidence synthesis?
Dunn, A. G., & Bourgeois, F. T. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa035 · Cited by 15
Industry Sponsor Influence in Clinical Trial Reporting in Canada: A Qualitative Interview Study
Morrow, R. L., Mintzes, B. J., Gray, G., Law, M. R., Garrison, S., & Dormuth, C. R. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.11.019 · Cited by 16
Publication Bias: Association of Diagnostic Accuracy in Radiology Conference Abstracts with Full-Text Publication
Cherpak, L. A., Korevaar, D. A., McGrath, T. A., Dang, W., Walker, D., Salameh, J., Sharifabadi, A. D., & McInnes, M. D. F. (2019) · Radiology · doi:10.1148/radiol.2019182206 · Cited by 16
Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology
Serpas, V., Raghav, K. P. S., Halperin, D. M., Yao, J. C., & Overman, M. J. (2018) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0627-2 · Cited by 14
Prescribed Walking for Glycemic Control and Symptom Management in Patients Without Diabetes Undergoing Chemotherapy
Hammer, M. J., Eckardt, P. A., Cartwright, F., & Miaskowski, C. A. (2020) · Nursing Research · doi:10.1097/nnr.0000000000000468 · Cited by 16
Outcome switching in randomized controlled oncology trials reporting on surrogate endpoints: a cross-sectional analysis
Delgado, A. F., & Delgado, A. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-09553-y · Cited by 15
Poor compliance of clinical trial registration among trials included in systematic reviews: a cohort study
Lindsley, K., Fusco, N., Teeuw, H., Mooij, E., Scholten, R., & Hooft, L. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.12.016 · Cited by 14
Information Disclosure and Competitive Dynamics: Evidence from the Pharmaceutical Industry
Kao, J. L. (2024) · Management Science · doi:10.1287/mnsc.2022.01161 · Cited by 14
Reporting guideline and clinical trial registration requirements in gastroenterology and hepatology journals
Jorski, A., Scott, J., Heavener, T. E., & Vassar, M. B. (2018) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000135 · Cited by 12
Publication Rates of Heart Failure Clinical Trials Remain Low
Psotka, M. A., Latta, F., Cani, D., Fiuzat, M., Sbolli, M., Barnett, S. D., Metra, M., & O’Connor, C. M. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.068 · Cited by 13
European non-commercial sponsors showed substantial variation in results reporting to the EU trial registry
Dal‐Ré, R., Goldacre, B. M., Mahíllo, I., & DeVito, N. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.11.005 · Cited by 13
ClinicalTrials.gov for Facilitating Rapid Understanding of Potential Harms of New Drugs: The Case of Checkpoint Inhibitors
Yang, A. W., Baxi, S. S., & Korenstein, D. R. (2018) · Journal of Oncology Practice · doi:10.1200/jop.2017.025114 · Cited by 13
Current Research and Development in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)—A Cross-Sectional Analysis of Clinical Trials Registered on ClinicalTrials.gov
Ukegjini, K., Guidi, M., Lehmann, K., Süveg, K., Putora, P. M., Čihorić, N., & Steffen, T. (2023) · Cancers · doi:10.3390/cancers15071926 · Cited by 12
mTCTScan: a comprehensive platform for annotation and prioritization of mutations affecting drug sensitivity in cancers
Li, M. J., Yao, H., Huang, D., Liu, H., Liu, Z., Xu, H., Qin, Y., Prinz, J., Xia, W., Wang, P., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx400 · Cited by 12
Transparency in ovarian cancer clinical trial results: ClinicalTrials.gov versus PubMed, Embase and Google scholar
Roberto, A., Radrezza, S., & Mosconi, P. (2018) · Journal of Ovarian Research · doi:10.1186/s13048-018-0404-1 · Cited by 12
Accelerating the Search for Interventions Aimed at Expanding the Health Span in Humans: The Role of Epidemiology
Newman, A. B., Kritchevsky, S. B., Guralnik, J. M., Cummings, S. R., Salive, M. E., Kuchel, G. A., Schrack, J. A., Morris, M. C., Weir, D. R., Baccarelli, A., et al. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz230 · Cited by 12
Open Science Standards at Journals that Inform Evidence-Based Policy
Grant, S., Mayo‐Wilson, E., Kianersi, S., Naaman, K., & Henschel, B. (2023) · Prevention Science · doi:10.1007/s11121-023-01543-z · Cited by 20
Clinical trials on drug-drug interactions registered in ClinicalTrials.gov reported incongruent safety data in published articles: an observational study
Jurić, D., Pranić, S. M., Tokalić, R., Milat, A. M., Mudnić, I., Pavličević, I., & Marušić, A. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.07.017 · Cited by 12
Adverse Events Associated with Nonsurgical Treatments for Urinary Incontinence in Women: a Systematic Review
Balk, E. M., Adam, G. P., Corsi, K., Mogul, A., Trikalinos, T. A., & Jeppson, P. C. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05028-0 · Cited by 12
Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysis
Chen, K. Y., Borglund, E. M., Postema, E. C., Dunn, A. G., & Bourgeois, F. T. (2022) · Clinical Trials · doi:10.1177/17407745221093567 · Cited by 13
A Scoping Review of Registered Clinical Studies on Mild Traumatic Brain Injury and Concussion (2000 to 2019)
Furlan, J. C., Radan, M. M., & Tator, C. H. (2020) · Neurosurgery · doi:10.1093/neuros/nyaa151 · Cited by 12
Improving the Prediction of Clinical Success Using Machine LearningPreprint
Munos, B. H., Niederreiter, J., & Riccaboni, M. (2021) · medRxiv · doi:10.1101/2021.02.01.21250864 · Cited by 12
Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries
Sha, Y., Ren, J., Jie, X., Li, P., Luo, J., Yin, J., Luo, L., Li, Z., & Luo, G. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.04.393 · Cited by 11
Race and ethnicity in multiple sclerosis phase 3 clinical trials: A systematic review
Ponzano, M., Signori, A., Bellavia, A., Carbone, A., Bovis, F., Schiavetti, I., Montobbio, N., & Sormani, M. P. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241254283 · Cited by 12
Characterization of Informed Consent Forms Posted on ClinicalTrials.gov
Tse, T., White, S., Gelinas, L. C., Morrell, W., Bierer, B. E., & Zarin, D. A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.35146 · Cited by 11
Self-citation
Noncommercial US Funders’ Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability
Whitlock, E. P., Dunham, K. M., DiGioia, K., Lazowick, E., Gleason, T., & Atkins, D. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.7498 · Cited by 13
Searching ClinicalTrials.gov did not change the conclusions of a systematic review
Wilson, L. M., Sharma, R., Dy, S. M., Waldfogel, J. M., & Robinson, K. A. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.07.009 · Cited by 12
Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov.
Cahan, A., & Anand, V. (2017) · PLOS ONE · doi:10.1371/journal.pone.0185886 · Cited by 10
Peer Reviewed Evaluation of Registered End-Points of Randomised Trials (the PRE-REPORT study): a stepped wedge, cluster-randomised trial
Jones, C. W., Adams, A., Misemer, B. S., Weaver, M. A., Schroter, S., Khan, H., Margolis, B., Schriger, D. L., & Platts-Mills, T. F. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-066624 · Cited by 10
Registration Practices of Randomized Clinical Trials in Rhinosinusitis
Ross, A., George, D., Wayant, C., Hamilton, T., & Vassar, M. B. (2019) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2019.0145 · Cited by 10
Priorities to Overcome Barriers Impacting Data Science Application in Emergency Care Research
Puskarich, M. A., Callaway, C. W., Silbergleit, R., Pines, J. M., Obermeyer, Z., Wright, D. W., Hsia, R. Y.-J., Shah, M. N., Monte, A. A., Limkakeng, A. T., et al. (2018) · Academic Emergency Medicine · doi:10.1111/acem.13520 · Cited by 10
Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID‐19 pandemic
Junqueira, D. R., & Rowe, B. H. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14598 · Cited by 9
Prostate cancer clinical trial completion: The role of geography
Stensland, K. D., Kaffenberger, S. D., George, A. K., Morgan, T. M., Miller, D. C., Salami, S. S., Dunn, R. L., Palapattu, G. S., Montgomery, J. S., Hollenbeck, B. K., et al. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106600 · Cited by 9
Publication trends of study protocols in rehabilitation
Jesus, T. S., & Colquhoun, H. L. (2018) · European Journal of Physical and Rehabilitation Medicine · doi:10.23736/s1973-9087.17.04858-4 · Cited by 10
The TOP factor: An indicator of quality to complement journal impact factor
Kepes, S., Banks, G. C., & Keener, S. K. (2020) · Industrial and Organizational Psychology · doi:10.1017/iop.2020.56 · Cited by 9
Identifying unreported links between ClinicalTrials.gov trial registrations and their published results
Liu, S., Bourgeois, F. T., & Dunn, A. G. (2021) · Research Synthesis Methods · doi:10.1002/jrsm.1545 · Cited by 8
Overview: comprehensive and carefully constructed strategies are required when conducting searches for adverse effects data
Golder, S., Peryer, G., & Loke, Y. K. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.05.019 · Cited by 9
Patient preferences when searching for clinical trials and adherence of study records to ClinicalTrials.gov guidance in key registry data fields
Schindler, T. M., Grieger, F., Zak, A., Rorig, R., Konka, K. C., Ellsworth, A., Pfitzer, C., Hodge, K., & Crandall, C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233294 · Cited by 11
Benchmarking Multiple Large Language Models for Automated Clinical Trial Data Extraction in Aging Research
Young, R., Matthews, A. M., & Poston, B. (2025) · Algorithms · doi:10.3390/a18050296 · Cited by 8
Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2014
Deane, B. R., & Porkess, S. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1415057 · Cited by 8
Transparency of results reporting for depression treatment studies in ClinicalTrials.gov: a cross-sectional study
Schmaling, K. B., Landon, H. S., Nguyen, T. B., & Kaplan, R. M. (2021) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2020-111641 · Cited by 9
Public access to clinical trials: Lessons from an organizational implementation of policy
Huang, G. D., Altemose, J. K., & O’Leary, T. J. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.04.002 · Cited by 9
Enrollment and reporting practices in pediatric general surgical randomized clinical trials: A systematic review and observational analysis
St‐Louis, E., Oosenbrug, M., Landry, T., & Baird, R. (2018) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2018.02.009 · Cited by 8
Reaping the Bounty of Publicly Available Clinical Trial Consent Forms.
Lynch, H. F., Largent, E. A., & Zarin, D. A. (2017) · PubMed · Cited by 9
Self-citation
Bringing data monitoring committee charters into the sunlight
DeMets, D. L., Zarin, D. A., Rockhold, F. W., Ellenberg, S. S., Fleming, T. R., & Wittes, J. T. (2023) · Clinical Trials · doi:10.1177/17407745231169499 · Cited by 8
Self-citation
Examining the use of consent forms to promote dissemination of research results to participants
Curran, D., Kekewich, M., & Foreman, T. (2018) · Research Ethics · doi:10.1177/1747016118798877 · Cited by 8
Trial results reporting: FDA Amendments Act Final Rule needs enforcement
von Elm, E. B., & Meerpohl, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30105-7 · Cited by 8
The Quality of Randomized Controlled Trials in High-impact Rheumatology Journals, 1998–2018
Putman, M., Ragle, A. H., & Ruderman, E. (2020) · The Journal of Rheumatology · doi:10.3899/jrheum.191306 · Cited by 8
Depression trial results: A cross-sectional study of ClinicalTrials.gov
Schmaling, K. B., & Kaplan, R. M. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.04.004 · Cited by 8
EAHAD haemophilia gene therapy clinical outcome database (EAHAD‐GTD)
Miesbach, W., Boban, A., Chowdary, P., Coppens, M., Crato, M., Jiménez‐Yuste, V., Klamroth, R., Makris, M., Mulders, G., & Peyvandi, F. (2024) · Haemophilia · doi:10.1111/hae.14981 · Cited by 7
Inadequate diversity of information resources searched in US-affiliated systematic reviews and meta-analyses: 2005–2016
Pradhan, R., Garnick, K., Barkondaj, B., Jordan, H. S., Ash, A. S., & Yu, H. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.05.024 · Cited by 6
Complete and transparent reporting of primary end points of randomized trials in the dermatology literature: A comparison of registered and published primary end points
Kim, D. Y., Oh, S., & Yoon, H. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.04.067 · Cited by 8
The Current Landscape of Atrial Fibrillation and Atrial Flutter Clinical Trials
Patel, R. B., Venkateswaran, R. V., Singh, A., Bhatt, D. L., Fonarow, G. C., PASSMAN, R. S., Butler, J., Yancy, C. W., & Vaduganathan, M. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.04.008 · Cited by 7
From publication bias to lost in information: why we need a central public portal for clinical trial data
Wieseler, B., & McGauran, N. (2020) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2020-111566 · Cited by 7
Undercutting efforts of precision medicine: roadblocks to minority representation in breast cancer clinical trials
Saini, G., Gogineni, K., Kittles, R. A., & Aneja, R. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06264-x · Cited by 8
Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA
Swanson, M. J., Johnston, J. L., & Ross, J. S. (2021) · Trials · doi:10.1186/s13063-021-05790-9 · Cited by 24
Improving the reporting and use of trial results in clinical trials registries: global practices, barriers, and recommendations
Kaul, T., Damen, J. A., Seidler, A. L., Willson, M. L., Karam, G., Idema, D. L., Kusters, M. P. T., Dowsett, M. A., Abutahoun, T. I. H., Hooft, L., et al. (2025) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2025.111901 · Cited by 8
Enough Talk, It's Time to Transform: A Call for Editorial Leadership for a Robust Science
Kepes, S., Keener, S. K., & McDaniel, M. A. (2018) · Industrial and Organizational Psychology · doi:10.1017/iop.2017.83 · Cited by 6
Reasons for Premature Conclusion of Late Phase Clinical Trials: An Analysis of ClinicalTrials.gov Registered Phase III Trials
Guinn, D., Wilhelm, E. E., & Shoulson, I. (2019) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479019830648 · Cited by 6
Comparison between protocols and publications for prognostic and predictive cancer biomarker studies
Doussau, A., Vinarov, E., Barsanti-Innes, B., & Kimmelman, J. (2019) · Clinical Trials · doi:10.1177/1740774519876912 · Cited by 6
Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects
Sinkala, M., Naran, K., Ramamurthy, D., Mungra, N., Dzobo, K., Martin, D. P., & Barth, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296511 · Cited by 6
Transparency and public accessibility of clinical trial information in Croatia: how it affects patient participation in clinical trials
Šolić, I., Stipčić, A., Pavličević, I., & Marušić, A. (2017) · Biochemia Medica · doi:10.11613/bm.2017.027 · Cited by 6
Reasons for and associated characteristics with early study termination: Analysis of ClinicalTrials.gov data on pregnancy topics
Shieh, C., Ofner, S., & Draucker, C. B. (2022) · Nursing Outlook · doi:10.1016/j.outlook.2021.12.006 · Cited by 6
Evolving a national clinical trials learning health system
Stensland, K. D., Richesson, R., Vince, R., Skolarus, T. A., & Sales, A. E. (2022) · Learning Health Systems · doi:10.1002/lrh2.10327 · Cited by 5
Large Clinical Trials and Registries—Clinical Research Institutes
Califf, R. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-849905-4.00028-9 · Cited by 5
New Requirements in the Reporting of Randomized Controlled Trials Published in Neurology to Foster Greater Transparency
Ziegler, A., Eliasziw, M., Howard, V. J., Kerr, W. T., Salter, A. R., Schneider, A. L. C., & Merino, J. G. (2024) · Neurology · doi:10.1212/wnl.0000000000209909 · Cited by 5
NeDRex-Web: An Interactive Web Tool for Drug Repurposing by Exploring Heterogeneous Molecular Networks
Maier, A., Rafiei, M., Anastasi, E., Zolotareva, O. I., Skelton, J., Elkjaer, M. L., Casas, A. I., Nogales, C., Schmidt, H. H. H. W., Kacprowski, T., et al. (2024) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm62325.2024.10822390 · Cited by 5
Summarising the Evidence for Drug Safety: A Methodological Discussion of Different Meta-Analysis Approaches
Prada-Ramallal, G., Takkouche, B., & Figueiras, A. (2017) · Drug Safety · doi:10.1007/s40264-017-0518-1 · Cited by 5
Not enough SPIRIT shown in the registration and reporting of orthodontic trial protocols
Eleftheriadi, I., Ioannou, T., Katechi, V., Seehra, J., & Pandis, N. (2022) · European Journal of Orthodontics · doi:10.1093/ejo/cjac027 · Cited by 5
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways
Pastò, B., Buzzatti, G., Schettino, C., Malapelle, U., Bergamini, A., Angelis, C. D., Musacchio, L., Dieci, M. V., Kuhn, E., Lambertini, M., et al. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104379 · Cited by 5
Statistical controversies in clinical research: data access and sharing—can we be more transparent about clinical research? Let’s do what’s right for patients
Rockhold, F. W. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx123 · Cited by 5
Trustworthiness of randomized trials in endocrinology—A systematic survey
González‐González, J. G., Dorsey-Treviño, E. G., Álvarez‐Villalobos, N. A., Barrera, F. J., González-Colmenero, A. D., Quintanilla‐Sánchez, C., Montori, V. M., & Rodríguez‐Gutiérrez, R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212360 · Cited by 5
E-cigarette manufacturers’ compliance with clinical trial reporting expectations: a case series of registered trials by Juul Labs
DeVito, N., Drysdale, H., McKee, M., & Goldacre, B. M. (2021) · Tobacco Control · doi:10.1136/tobaccocontrol-2020-056221 · Cited by 6
Comparing and Contrasting A Priori and A Posteriori Generalizability Assessment of Clinical Trials on Type 2 Diabetes Mellitus.
He, Z., González-Izquierdo, A., Denaxas, S., Sura, A., Guo, Y. M., Hogan, W. R., Shenkman, E. A., & Bian, J. (2017) · PubMed Central · Cited by 5
Reporting bias in completed epilepsy intervention trials: A cross-sectional analysis
Rayi, A., Thompson, S., Gloss, D. S., & Malhotra, K. (2018) · Epilepsy Research · doi:10.1016/j.eplepsyres.2018.03.022 · Cited by 5
Clinical Trials on Diabetic Nephropathy: A Cross-Sectional Analysis
Modafferi, S., Ries, M., Calabrese, V., Schmitt, C. P., Nawroth, P. P., Kopf, S., & Peters, V. (2019) · Diabetes Therapy · doi:10.1007/s13300-018-0551-9 · Cited by 5
Machine Learning with Statistical Imputation for Predicting Drug ApprovalsPreprint
Lo, A. W., Siah, K. W., & Wong, C. H. (2017) · SSRN Electronic Journal · doi:10.2139/ssrn.2973611 · Cited by 5
Human Forest vs. Random Forest in Time-Sensitive COVID-19 Clinical Trial PredictionPreprint
Atanasov, P. D., Joseph, R., Feijoo, F., Marshall, M., Conway, A., & Siddiqui, S. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3981732 · Cited by 6
CONSORT-C 2026 explanation and elaboration: recommendations for enhancing the reporting and impact of paediatric randomised trials
Baba, A., Smith, M., Potter, B. K., Chan, A.-W., Moher, D., Toulany, A., Doherty-Kirby, A., Nafría, B., Stratton, C., Gale, C., et al. (2026) · BMJ · doi:10.1136/bmj-2025-085063 · Cited by 4
A retrospective analysis of serious adverse events and deaths in U.S.-based lifestyle clinical trials for cognitive health
Key, M. N., Shaw, A. R., Erickson, K. I., Burns, J. M., & Vidoni, E. D. (2024) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2024.101277 · Cited by 4
A comparison of registered and published primary outcomes in clinical trials of opioid use disorder: ACTTION review and recommendations
Kleykamp, B. A., Ferguson, M. C., McNicol, E. D., Bixho, I., Matthews, M. L., Turk, D. C., Dworkin, R. H., & Strain, E. C. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109447 · Cited by 4
ClinicalTrials.gov
Gresham, G. K. (2022) · Springer eBooks · doi:10.1007/978-3-319-52636-2_266 · Cited by 4
Are large prospective trials on antidepressants in mental disorders seeding trials? A descriptive study of trials registered on ClinicalTrials.gov
Martineau, S., Cristea, I. A., Chevance, A., Fanelli, D., & Naudet, F. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-062913 · Cited by 4
Sex, racial, and ethnic disparities in motor neuron disease: clinical trial enrolment
Tsai, C., Tao, B. K.-L., Wong, M., Suntharalingam, H., Abrahão, A., & Barnett, C. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2358793 · Cited by 4
Cancer Immunotherapy Trials Underutilize Immune Response Monitoring
Connell, C. M., Raby, S., Beh, I., Flint, T. R., Williams, E. H., Fearon, D. T., Jodrell, D. I., & Janowitz, T. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0226 · Cited by 4
Cross-Sectional Survey of Clinical Trials of Stem Cell Therapy for Heart Disease Registered at ClinicalTrials.gov
Yang, R., Zhang, Y., Liao, X., Guo, R., Yao, Y., Huang, C., & Li, Q. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.630231 · Cited by 4
ClinicalTrials.gov
Gresham, G. K. (2020) · Springer eBooks · doi:10.1007/978-3-319-52677-5_266-1 · Cited by 4
Effectiveness of music-based interventions for cognitive rehabilitation in Parkinson’s disease: a systematic review of randomized controlled clinical trials
Citon, L. F., & Hamdan, A. (2023) · Psicologia: Reflexão e Crítica · doi:10.1186/s41155-023-00259-x · Cited by 3

Authors: Zarin, D. A., Tse, T., Williams, R. J., & Carr, S.
Affiliations: National Institutes of Health (US)
ORCID: Zarin, Deborah A.
Tse, Tony
Williams, Rebecca J.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2016-11-17
Volume: 375
Issue: 20
Pages: 1998-2004
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmsr1611785
PMC: PMC5225905
OpenAlex: W2520965749
Cited by: 332
References: 11
Citations by year: 2026: 37 · 2025: 21 · 2024: 20 · 2023: 21 · 2022: 20 · 2021: 34 · 2020: 43 · 2019: 34 · 2018: 46 · 2017: 51 · 2016: 4
FWCI: 56.25
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: public-domain
Locations: New England Journal of Medicine (publishedVersion, public-domain)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (Z99 LM999999)
Topics: Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Regulation
Keywords: ClinicalTrials.gov, clinical trial registration, final rule, clinical trial reporting, regulatory fees, Investigational New Drug application
MeSH terms: Clinical Trials as Topic, Registries, United States, United States Dept. of Health and Human Services, United States Food and Drug Administration, Databases, Factual, Government Regulation, Mandatory Programs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Trial Reporting in ClinicalTrials.gov — The Final Rule

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks